Showing results (101-110 of 276) with videos related to
Sort By:
Pageof 28
Journal of Virology|February 15, 2005
Maturation of papillomavirus capsidsChristopher B Buck, Cynthia D Thompson, Yuk-Ying S Pang, et al.Antiviral Research|July 10, 2007
Humoral and cellular immune responses to airway immunization of mice with human papillomavirus type 16 virus-like particles and mucosal adjuvantsVéronique Revaz, Rinaldo Zurbriggen, Christian Moser, et al.Vaccine|February 10, 2009
Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinomaGiuseppina Cantarella, Matthias Liniger, Armando Zuniga, et al.International Journal of Cancer|February 6, 1999
A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among childrenV af Geijersstam, C Eklund, Z Wang, et al.Current Opinion in Molecular Therapeutics|March 16, 2001
Papillomavirus virus-like particles as anticancer vaccinesD M Da Silva, M P Velders, M P Rudolf, et al.The EMBO Journal|January 1, 1990
The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylationM S Barbosa, C Edmonds, C Fisher, et al.Nature Structural Biology|May 1, 1997
Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolutionB L Trus, R B Roden, H L Greenstone, et al.Journal of the National Cancer Institute|April 6, 1994
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16R Kirnbauer, N L Hubbert, C M Wheeler, et al.The Lancet. Microbe|May 15, 2026
Exceeding expectations: factors contributing to the potency of human papillomavirus vaccinesJohn T Schiller, Rhonda C Kines, Patricia M Day, et al.Clinical Immunology (Orlando, Fla.)|April 23, 2003
Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cellsPetra Lenz, Cynthia D Thompson, Patricia M Day, et al.Pageof 28